Chad Lunt, MD
Obstetrics · St George, UTNPI 1396790309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 37.9% of the total. Reporting peaked in 2022 at $398 and has fallen 62.6% since, to $149 in 2025.
Across 75 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$609
- Biogen$163
- Evofem Biosciences, Inc.$99
- Therapeuticsmd, Inc.$98
- Sumitomo Pharma America, Inc.$78
- Mayne Pharma Commercial LLC$78
- plus $484 from 16 others
What the payments were for
- Food & beverage$1,609100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $609 |
| Biogen | 7 | $163 |
| Evofem Biosciences, Inc. | 5 | $99 |
| Therapeuticsmd, Inc. | 5 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| Mayne Pharma Commercial LLC | 3 | $78 |
| Bayer | 4 | $64 |
| Coloplast | 1 | $63 |
| Astellas Pharma US Inc | 2 | $53 |
| Medical Device Business Services, Inc. | 1 | $52 |
| Johnson & Johnson | 1 | $33 |
| Convatec Inc. | 1 | $33 |
| Hologic Sales And Service, LLC | 2 | $31 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Urovant Sciences Inc | 1 | $19 |
| Organon | 1 | $19 |
| BD | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Myovant Sciences Inc. | 1 | $12 |
How this compares
Too few obstetrics providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $1,316 |
| Medroxyprogesterone Acetate | 17 | $189 |
| Ibuprofen | 12 | $60 |
| Misoprostol | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in St George
- Cameron LeavittSt George$3K
- James PetersonSalt Lake City$11K
- Layne SmithDraper$8K
- Shane ChristensenSalt Lake City$6K
- Gayle StewartSalt Lake City$5K
- Thomas ConnerSalt Lake City$3K
- Robert LaterSandy$2K
- Douglas AllenPleasant Grove$1K
- Eileen JoyceVernal$1K
- Samuel HeywoodOrem$201
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.